LAM
UTHR icon

L2 Asset Management’s United Therapeutics UTHR Stock Holding History

L2 Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.81M Sell
10,732
-3,359
-24% -$1.89M 0.6% 54
2026
Q1 		$8.36M Buy
14,091
+2,102
+18% +$1.05M 0.79% 35
2025
Q4 		$5.84M Sell
11,989
-2,334
-16% -$1.09M 0.78% 42
2025
Q3 		$6M Buy
14,323
+5,378
+60% +$1.81M 0.87% 36
2025
Q2 		$2.57M Sell
8,945
-4,952
-36% -$1.48M 0.42% 68
2025
Q1 		$4.28M Buy
13,897
+1,320
+10% +$452K 0.88% 40
2024
Q4 		$4.44M Buy
12,577
+2,570
+26% +$945K 0.96% 35
2024
Q3 		$3.59M Buy
10,007
+7,643
+323% +$2.58M 0.97% 31
2024
Q2 		$753K Buy
2,364
+300
+15% +$79.4K 0.23% 85
2024
Q1 		$474K Buy
2,064
+79
+4% +$17.8K 0.16% 105
2023
Q4 		$436K Buy
1,985
+1,406
+243% +$324K 0.18% 99
2023
Q3 		$1.43M Sell
579
-11,438
-95% -$2.63M 0.67% 48
2023
Q2 		$2.65M Buy
12,017
+1,563
+15% +$346K 1.3% 27
2023
Q1 		$2.34M Sell
10,454
-138
-1% -$34K 1.29% 22
2022
Q4 		$2.95M Buy
10,592
+13
+0.1% +$3.28K 1.83% 12
2022
Q3 		$2.21M Buy
+10,579
New +$2.37M 1.52% 21

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

L2 Asset Management's UTHR Position: Q2 2026 in Review

L2 Asset Management reduced its United Therapeutics (UTHR) stake by 24% in Q2 2026, selling an estimated $1.89M and leaving 10,732 shares worth $5.81M. The position accounts for 0.6% of the portfolio, ranked #54.

L2 Asset Management first reported a position in UTHR in Q3 2022 and has held it in 16 quarters since. The position peaked at $8.36M in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • L2 Asset Management held 10,732 shares of United Therapeutics worth $5.81M as of Q2 2026.
  • L2 Asset Management sold 3,359 United Therapeutics shares in Q2 2026, an estimated $1.89M.
  • United Therapeutics made up 0.6% of L2 Asset Management's portfolio in Q2 2026, its #54 holding.
  • L2 Asset Management first reported a position in United Therapeutics in Q3 2022 and has held it in 16 quarters since.
  • L2 Asset Management's United Therapeutics position peaked at $8.36M in Q1 2026.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on L2 Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.